YCY
NYSE · N/A
Aa Mission Acquisition-A
$10.37
+0.04 (+0.39%)
Open$10.31
Previous Close$10.33
Day High$10.37
Day Low$10.31
52W High$10.35
52W Low$9.90
Volume—
Avg Volume90.4K
Market Cap122.52M
P/E Ratio98.79
EPS$0.07
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 39.01M | 40.32M | 32.67M |
| Net Income | 1.80M | 2.30M | 1.57M |
| Profit Margin | 4.6% | 5.7% | 4.8% |
| EBITDA | 3.33M | 3.18M | 2.52M |
| Free Cash Flow | 1.88M | 2.00M | 1.33M |
| Rev Growth | +9.1% | -6.2% | +4.8% |
| Debt/Equity | 0.57 | 0.61 | 0.48 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $0.75 | -20.08% | — | 585.99M |
| PICS | Pics Nv | $6.89 | -7.14% | 4.1 | 961.54M |
| DMII | Drugs Made In America Acquis | $10.26 | +0.20% | 50.1 | 652.61M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.62 | +0.05% | 21.3 | 168.92M |
| CEPF | Cantor Equity Partners-Cl A | $10.35 | +0.19% | 41.5 | 590.36M |